Cargando…
High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
BACKGROUND: No reliable prognostic markers exist for squamous cell carcinoma of the tongue, and its prognosis can even in early stages be unpredictable and survival poor despite treatment. A potential marker is oncoprotein cancerous inhibitor of PP2A (CIP2A), which acts as a prognostic marker in gas...
Autores principales: | Böckelman, C, Hagström, J, Mäkinen, L K, Keski-Säntti, H, Häyry, V, Lundin, J, Atula, T, Ristimäki, A, Haglund, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111200/ https://www.ncbi.nlm.nih.gov/pubmed/21610708 http://dx.doi.org/10.1038/bjc.2011.167 |
Ejemplares similares
-
Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
por: Häyry, V, et al.
Publicado: (2010) -
Prognostic role of CIP2A expression in serous ovarian cancer
por: Böckelman, C, et al.
Publicado: (2011) -
Independent prognostic value of fascin immunoreactivity in stage III–IV colonic adenocarcinoma
por: Puppa, G, et al.
Publicado: (2007) -
Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer
por: Ahmad, I, et al.
Publicado: (2013) -
Expression and prognostic value of transcription factor PROX1 in colorectal cancer
por: Skog, M, et al.
Publicado: (2011)